-+ 0.00%
-+ 0.00%
-+ 0.00%

MSD: Overall survival data are not mature, but it has been observed that Intismeran and Keytruda show an advantageous trend in terms of overall survival.

Zhitongcaijing·10/22/2026 18:33:19
Listen to the news
MSD: Overall survival data are not mature, but it has been observed that Intismeran and Keytruda show an advantageous trend in terms of overall survival.